TCGX Acquisition Corp. II Class A Ordinary Shares

TCGX Acquisition Corp. II Class A Ordinary Shares(TCXB)股票分析

$10.250

+0.050 (+0.49%)收盘时

Loading chart…
最高
10.250
开盘
10.170
成交量加权均价
10.21
成交量
1.32K
市值
—
最低
10.140
成交额
13.50K
企业价值/息税折旧摊销前利润(TTM)
0.00

AI 分析 of TCGX Acquisition Corp. II Class A Ordinary Shares (TCXB)

持有

Currently, Tcgx Acquisition Corp. II is trading at $10.10, which is 5.7% above its 52-week low of $10.00 but significantly below its 52-week high of $11.74. The stock has shown a year-to-date change of +1.00%, indicating stability but not strong growth. The lack of a P/E ratio and other valuation metrics suggests uncertainty in its financial performance. The main risk is its low trading volume of 1312 shares today compared to an average of 78104 shares over the last 20 days, indicating low investor interest.

估值指标

TCGX Acquisition Corp. II Class A Ordinary Shares(TCXB)当前预期市盈率为 0.00,5 年平均预期市盈率为 。

预期市盈率

5 年均值 P/E
当前P/E
0.00

预期 EV/EBITDA

5 年均值 EV/EBITDA
当前EV/EBITDA
0.00

预期市销率

5 年均值 P/S
当前P/S
0.00

事件时间线

2026-10-19 (ET)

12:00:00

City Therapeutics and Iambic Therapeutics Successfully Debut in Market

2026-10-16 (ET)

11:30:00

TCGX Acquisition Corp. II Prices IPO at $10 per Share

资讯

TCXB 常见问题 —— 由 Alphio AI 解答

Currently, Tcgx Acquisition Corp. II is trading at $10.10, which is 5.7% above its 52-week low of $10.00 but significantly below its 52-week high of $11.74. The stock has shown a year-to-date change of +1.00%, indicating stability but not strong growth. The lack of a P/E ratio and other valuation metrics suggests uncertainty in its financial performance. The main risk is its low trading volume of 1312 shares today compared to an average of 78104 shares over the last 20 days, indicating low investor interest.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易